Does GIP Provide Added Glycemic Benefit in T2D?

Published Date: 20 Aug 2026

When added to semaglutide or placebo, glucose-dependent insulinotropic polypeptide (GIP) shows no effect on glycemic control in type 2 diabetes.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Alternative breast imaging techniques beyond mammography.

2.

Researchers use genomic technology to investigate aggressive skin cancer linked to burn scars

3.

Capivasertib Wins Metastatic Prostate Cancer Approval

4.

Fixed-Duration Combo Shows Promise for Relapsed MCL

5.

Q&A: Breast cancer facts that could save lives


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot